Category Archives: Manufacturing

Tiered Pricing Not Always a Win-Win

By Ben Comer | Published: November 22, 2011
Tiered pricing, or selling critical medicines to developing countries at a standardized discount price, can improve access in the short term, but arbitrary demographic groupings and misaligned incentives often stack the deck in favor of manufacturers, not patients.
Also posted in Corporate Responsibility, Emerging Markets, Global, IP, Market Access, R&D, Strategy, pricing | 2 Comments

New Year Night Stalkers: What Will Keep the C-Suiters Awake in 2011

By William Looney | Published: January 5, 2011
New Year Night Stalkers Eight Strategic Issues that Should Keep “C Suiters” Reaching for the NoDoz in 2011 The consensus is that 2011 will be a bad year for big pharma.  It must confront a breaking wave of patent expirations, while fiscal retrenchment has created an innovation cycle in reverse as payers find new ways to curb [...]
Also posted in Marketing, R&D, Regulatory, Strategy, Technology, compliance | Tagged , , | 5 Comments

Brazil Profile: Latin America's Giant Repositions for Pharma Growth

By William Looney | Published: October 27, 2010
Brazil claims a bright future as a drug research and clinical trials site — but IP issues continue to raise concerns among the multinational investor community. Health and regulatory officials of Brazil are making the rounds with a message for pharmaceutical companies and clinical research sponsors about what a great place it is to do [...]
Also posted in Emerging Markets, FDA, Global, Legal, R&D, Regulatory, Strategy, Supply Chain | Leave a comment

Affordable Access to HIV Meds on the Way

By Jennifer Ringler | Published: October 1, 2010
UNITAID’s Medicines Patent Pool seeks to bring costly HIV/AIDS treatments and other essential drugs to low-income countries by requiring patent-holders to license their technologies to generics manufacturers. Will pledges of support from the NIH bring some of these patent-holders back to the negotiating table? A new way for patients to have access to affordable HIV and [...]
Also posted in Deals | Tagged , , , | Leave a comment

Judgment Day for Pfizer Factories

By Oriana Schwindt | Published: May 19, 2010
For once, pharma sales reps and R&D guys can breathe a sigh of relief. The latest round of industry layoffs comes from Pfizer, but this time it will affect the manufacturing force, which will be downsized by 6,000 employees by 2015. In 2006, the company announced plans to save $4 billion to $5 billion, and after [...]
Also posted in Europe, Global, News, Strategy | Tagged , , , , , , | Leave a comment